|
|
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study.
Mira Tout
,
Olivier Casasnovas
,
Michel Meignan
,
Thierry Lamy
,
Franck Morschhauser
et al.
Journal articles
hal-01547802v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma
Guillemette Fouquet
,
Lionel Karlin
,
Margaret Macro
,
Denis Caillot
,
Murielle Roussel
et al.
Journal articles
hal-01728968v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
Steven Le Gouill
,
Catherine Thieblemont
,
Lucie Oberic
,
Anne Moreau
,
Krimo Bouabdallah
et al.
Journal articles
hal-02329536v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS.
Arnaud Pigneux
,
Jean-Luc Harousseau
,
Francis Witz
,
Mathieu Sauvezie
,
Marie-Christine Bene
et al.
Journal articles
hal-00849638v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
Maroulio Pertesi
,
Maxime Vallée
,
Xiaomu Wei
,
Maria Revuelta
,
Perrine Galia
et al.
Journal articles
hal-02190723v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group
Thorsten Braun
,
Sophie Cereja
,
Sylvie Chevret
,
Emmanuel Raffoux
,
Marie Beaumont
et al.
Journal articles
hal-01237097v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS).
Franck Morschhauser
,
Nicolas Mounier
,
Catherine Sebban
,
Pauline Brice
,
Phillippe Solal-Celigny
et al.
Journal articles
hal-00744246v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy and safety of defibrotide in the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following hematopoietic stem cell transplantation: Interim results from the defifrance study
Mohamad Mohty
,
Myriam Labopin
,
Delphine Lebon
,
Ana Berceanu
,
Charlotte Jubert
et al.
Bone Marrow Transplantation, 2019, 54 (1), pp.231-232
Journal articles
hal-03606394v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group
Sophie Michallet
,
Arnaud Campidelli
,
Helene Lequeu
,
Marie-Sarah Dilhuydy
,
Olivier Tournilhac
et al.
Journal articles
hal-01653723v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of HLA of Winning Cord Blood Unit on Outcomes after Double Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee Cellular Therapy and Immunobiology Working Party and the Acute Leukemia Working Party of the EBMT
Federica Giannotti
,
Annalisa Ruggeri
,
Myriam Labopin
,
Jan Cornelissen
,
Mauricette Michallet
et al.
Journal articles
hal-01290435v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study
Hervé Tilly
,
Franck Morschhauser
,
Olivier Casasnovas
,
Thierry Jo Molina
,
Pierre Feugier
et al.
Journal articles
hal-02329073v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia
Caroline Dartigeas
,
Eric van den Neste
,
Christian Berthou
,
Hervé Maisonneuve
,
Stéphane Leprêtre
et al.
Journal articles
hal-01272930v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study
Caroline Dartigeas
,
Eric van den Neste
,
Julie Léger
,
Hervé Maisonneuve
,
Christian Berthou
et al.
Journal articles
hal-01712402v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French network
Laurence Schenone
,
Caroline Houillier
,
Marie Laure Tanguy
,
Sylvain Choquet
,
Kossi Agbetiafa
et al.
Journal articles
hal-03703797v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study
Mohamad Mohty
,
Didier Blaise
,
Régis Peffault de Latour
,
Myriam Labopin
,
Jean Henri Bourhis
et al.
Journal articles
hal-03915550v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.
Emmanuel Bachy
,
Roch Houot
,
Franck Morschhauser
,
Anne Sonet
,
Pauline Brice
et al.
Journal articles
hal-00933219v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts
Sarah Huet
,
Bruno Tesson
,
Jean-Philippe Jais
,
Andrew Feldman
,
Laura Magnano
et al.
Journal articles
hal-01788996v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study.
Bruno Lioure
,
Marie C Béné
,
Arnaud Pigneux
,
Anne Huynh
,
Patrice Chevallier
et al.
Journal articles
hal-00849702v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial
Mathilde Hunault-Berger
,
N. Maillard
,
C. Himberlin
,
C. Recher
,
Aline Schmidt-Tanguy
et al.
Journal articles
inserm-01814864v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC
Amandine Le Bourgeois
,
Myriam Labopin
,
Ambroise Marçais
,
Regis Peffault de Latour
,
Didier Blaise
et al.
Journal articles
hal-02977222v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months
Geoffrey Foulon-Pinto
,
Georges Jourdi
,
Julien Perrin
,
Johan Abdoul
,
Guillaume Paris
et al.
Journal articles
hal-03102064v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Induction-related cost of patients with acute myeloid leukaemia in France.
Virginie Nerich
,
Bruno Lioure
,
Maryline Rave
,
Christian Recher
,
Arnaud Pigneux
et al.
Journal articles
istex
hal-00849659v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study
Franck Morschhauser
,
Steven Le Gouill
,
Pierre Feugier
,
Sarah Bailly
,
Emmanuelle Nicolas-Virelizier
et al.
Journal articles
hal-02586078v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|